Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL465208 (Salidroside) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Inhibition of COX1 | B | 4.14 | pIC50 | 72000 | nM | IC50 | J Nat Prod (2005) 68: 985-991 [PMID:16038536] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Competitive inhibition of human recombinant MAO-B expressed in baculovirus infected BTI cells assessed as inhibition of 4-hydroxyquinoline formation using varying concentration of kynuramine as substrate preincubated with enzyme for 10 mins followed by addition of substrate and measured after 15 mins by Lineweaver-Burk plot analysis | B | 6.04 | pKi | 920 | nM | Ki | Eur J Med Chem (2021) 209: 112935-112935 [PMID:33097301] |
GtoPdb | - | - | 6.04 | pKi | 920 | nM | Ki | Eur J Med Chem (2021) 209: 112935 [PMID:33097301] |
ChEMBL | Inhibition of human recombinant MAO-B expressed in baculovirus infected BTI cells assessed as inhibition of 4-hydroxyquinoline formation using kynuramine as substrate preincubated with enzyme for 10 mins followed by addition of substrate and measured after 15 mins by fluorescence spectrophotometry | B | 6.09 | pIC50 | 810 | nM | IC50 | Eur J Med Chem (2021) 209: 112935-112935 [PMID:33097301] |
Ribonuclease HI in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1770039] [UniProtKB: P0A7Y4] | ||||||||
ChEMBL | Inhibition of Escherichia coli recombinant ribonuclease H after 30 mins by FRET quenching assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 2840-2844 [PMID:21489793] |
ChEMBL | Inhibition of Escherichia coli recombinant ribonuclease H after 30 mins by FRET quenching assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 2840-2844 [PMID:21489793] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]